Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2021
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 StudyStefano Luminari, Martina Manni, Sara Galimberti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trialJohn M M Raemaekers, Marc P E André, Massimo Federico, et al.American Journal of Hematology|May 14, 2025
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 TrialRexhep Durmo, Stephane Chauvie, Carla Minoia, et al.Leukemia & Lymphoma|March 8, 2017
Report of the 6th International Workshop on PET in lymphomaCristina Nanni, Anne Ségolène Cottereau, Egesta Lopci, et al.Clinical and Translational Imaging|July 19, 2021
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretationMassimiliano Casali, Chiara Lauri, Corinna Altini, et al.Movement Disorders Clinical Practice|September 9, 2025
Artificial Intelligence Predicts GBA1 Mutated Status in Parkinson's Disease PatientsGiulia Di Rauso, Alessandro Ghibellini, Sara Grisanti, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2024
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trialLuca Guerra, Stephane Chauvie, Federico Fallanca, et al.Journal of Endocrinological Investigation|July 23, 2025
Italian guidelines for the management of adult individuals with primary hypothyroidism outside pregnancyRinaldo Guglielmi, Caterina Mian, Roberto Novizio, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|April 22, 2024
Italian Guidelines for the Management of Sporadic Primary HyperparathyroidismFabio Vescini, Giorgio Borretta, Iacopo Chiodini, et al.Global & Regional Health Technology Assessment|July 28, 2025
Micro-costing analysis from Italian Guidelines for the management of sporadic primary hyperparathyroidismValentini Ilaria, Michele Basile, Fabio Vescini, et al.Pageof 14